FDA Clearance Tracker · K172286
Automated Blood Coagulation Analyzer CS-2500
Last checked: Nov 20, 2026Latest source record: Dec 18, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 18, 2017
Substantially Equivalent
Time to decision
143 days
Received Jul 28, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K172286
- Device name
- Automated Blood Coagulation Analyzer CS-2500
- Applicant location
- Marburg, DE
- Received
- Jul 28, 2017
- Decided
- Dec 18, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 864.5425
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JPA. The earliest in FDA's data is K760594, decided Nov 24, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K172286
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Siemens Healthcare Diagnostic Products GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253985 · Decided Aug 11, 2026 · 242 days after receipt
Device type: Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (DAP) · Laboratory Medicine & Pathology
- INNOVANCE Antithrombin510(k)
K242952 · Decided Mar 28, 2025 · 184 days after receipt
Device type: Antithrombin Iii Quantitation (JBQ) · Laboratory Medicine & Pathology
- CardioPhase® hsCRP510(k)
K232624 · Decided Nov 27, 2023 · 90 days after receipt
Device type: System, Test, C-Reactive Protein (DCN) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.